Marie-claude C. Daigneault-Bourgeois
Montreal, QC H2X0A9, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Estrogen-mediated NF-κB blockade enables breast cancer sensitivity to oncolytic VSV virotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 10, 2025
Estrogen-mediated NF-κB blockade enables breast cancer sensitivity to oncolytic VSV virotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 10, 2025
The Immunoproteasome Is Expressed but Dispensable for a Leukemia Infected Cell Vaccine.
Journal: Vaccines
Published: July 03, 2025
RNAi Screening in Tumor Cells Identifies Artificial microRNAs That Improve Oncolytic Virus Replication.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 11, 2025
From oncogenesis to prognosis: the roles of the immunoproteasome in cancer.
Journal: Frontiers in immunology
Published: April 01, 2025
The Small GTPase Ran Increases Sensitivity of Ovarian Cancer Cells to Oncolytic Vesicular Stomatitis Virus.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 06, 2024
Ultrasound and Microbubble Mediated Delivery of Virus-Sensitizing Drugs Improves In Vitro Oncolytic Virotherapy Against Breast Cancer Cells.
Journal: Ultrasound in medicine & biology
Published: August 20, 2024
Oncolytic vesicular stomatitis virus alone or in combination with JAK inhibitors is effective against ovarian cancer.
Journal: Molecular therapy. Oncology
Published: March 20, 2024
PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I IFN pathway.
PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I IFN pathway.
Journal: The Journal of experimental medicine
Published: October 11, 2022
High Levels of MFG-E8 Confer a Good Prognosis in Prostate and Renal Cancer Patients.
Journal: Cancers
Published: April 21, 2022
In silico trials predict that combination strategies for enhancing vesicular stomatitis oncolytic virus are determined by tumor aggressivity.
Journal: Journal for immunotherapy of cancer
Published: December 22, 2020
The pros and cons of interferons for oncolytic virotherapy.
Journal: Cytokine & growth factor reviews
Published: June 11, 2020
Last Updated: 09/26/2026